Effective with date of service Dec. 30, 2021, Medicaid and NC Health Choice cover ropeginterferon alfa-2b-njft injection, for subcutaneous use (BESREMI®).
Medicaid Bulletin Monthly Digest
Articles beginning January 2018 are available in the blog format.